Table 1:
Associations between Characteristics of Consent Forms and Funding Source
| Pharmaceutical-funded | NCTN | R01-funded or similar non-government grant | Mixed Funding Source | |||
|---|---|---|---|---|---|---|
| 106 (34) | 145 (46) | 44 (14) | 20 (6) | 315 | ||
| Phase of Trial | ||||||
| I | 48 (45) | 10 (7) | 14 (32) | 8 (40) | 80 (26) | <0.0001** |
| II | 32 (30) | 84 (58) | 26 (59) | 7 (35) | 149 (47) | |
| III | 19 (18) | 47 (32) | 0 (0) | 3 (15) | 69 (22) | |
| Missing | 7 (7) | 4 (3) | 4 (9) | 2 (10) | 17 (5) | |
| Year Trial Opened | ||||||
| 2004 | 14 (13) | 27 (19) | 9 (20) | 6 (30) | 56 (18) | 0.38*** |
| 2005 | 11 (10) | 25 (17) | 7 (16) | 4 (20) | 47 (15) | |
| 2006 | 9 (8) | 23 (16) | 3 (7) | 1 (5) | 36 (11) | |
| 2007 | 20 (19) | 19 (13) | 5 (12) | 2 (10) | 46 (15) | |
| 2008 | 22 (21) | 21 (14) | 11 (25) | 2 (10) | 56 (18) | |
| 2009 | 26 (25) | 27 (19) | 9 (20) | 4 (20) | 66 (21) | |
| 2010 | 4 (4) | 3 (2) | 0 (0) | 1 (5) | 8 (2) | |
| Accrual goal met? | ||||||
| Yes | 52 (49) | 31 (21) | 5 (11) | 7 (35) | 95 (30) | 001** |
| No | 35 (33) | 24 (17) | 18 (41) | 5 (25) | 82 (26) | |
| Missing | 19 (18) | 90 (62) | 21 (48) | 8 (40) | 138 (44) | |
*
Missing data were excluded from analyses.
**
Chi-square test
***
Fisher’s Exact test